0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......

Journal Articles

in Psychopharmacology
 21-40 of 327 Articles
JAMA Pediatrics | 
Original Investigation | 
Briannon C. O’Connor, PhD; R. Eric Lewandowski, PhD; Stephanie Rodriguez, BS; et al.
JAMA Pediatr. 2016;170(4):373-380. doi:10.1001/jamapediatrics.2015.4158.

JAMA | 
Editorial | 
Joshua M. Sharfstein, MD; Bruce M. Psaty, MD, PhD
JAMA. 2016;315(10):984-986. doi:10.1001/jama.2016.1461.

JAMA | 
News From the Centers for Disease Control and Prevention | 
JAMA. 2016;315(10):971. doi:10.1001/jama.2016.1631.

JAMA Psychiatry | 
Original Investigation | 
Britta Galling, MD; Alexandra Roldán, MD; René E. Nielsen, MD, PhD; et al.
JAMA Psychiatry. 2016;73(3):247-259. doi:10.1001/jamapsychiatry.2015.2923.
Includes: Supplemental Content

JAMA Neurology | 
Editorial | 
Helen S. Mayberg, MD
JAMA Neurol. 2016;73(3):270-271. doi:10.1001/jamaneurol.2015.5048.

JAMA Psychiatry | 
Editorial | 
John M. Kane, MD; Christoph U. Correll, MD
JAMA Psychiatry. 2016;73(3):187-188. doi:10.1001/jamapsychiatry.2015.2966.

JAMA Psychiatry | 
Original Investigation | 
Myrto T. Samara, MD; Markus Dold, MD; Myrsini Gianatsi, MSc; et al.
JAMA Psychiatry. 2016;73(3):199-210. doi:10.1001/jamapsychiatry.2015.2955.
Includes: CME, Supplemental Content

JAMA Pediatrics | 
Editorial | 
Bryan H. King, MD, MBA
JAMA Pediatr. 2016;170(2):111-112. doi:10.1001/jamapediatrics.2015.3493.

JAMA Pediatrics | 
Original Investigation | 
Takoua Boukhris, MSc; Odile Sheehy, MSc; Laurent Mottron, MD, PhD; et al.
JAMA Pediatr. 2016;170(2):117-124. doi:10.1001/jamapediatrics.2015.3356.
Includes: CME, Supplemental Content

JAMA Psychiatry | 
Editorial | 
Shitij Kapur, MD, PhD; Tiago Reis Marques, MD, PhD
JAMA Psychiatry. 2016;73(2):107-108. doi:10.1001/jamapsychiatry.2015.2872.

JAMA Psychiatry | 
Original Investigation | 
Mette Ø. Nielsen, PhD; Egill Rostrup, DMSc; Sanne Wulff, PhD; et al.
JAMA Psychiatry. 2016;73(2):121-128. doi:10.1001/jamapsychiatry.2015.2582.
Includes: CME, Supplemental Content

JAMA Psychiatry | 
Original Investigation | 
Raymond W. Lam, MD; Anthony J. Levitt, MBBS; Robert D. Levitan, MD, MSc; et al.
JAMA Psychiatry. 2016;73(1):56-63. doi:10.1001/jamapsychiatry.2015.2235.
Includes: CME, Supplemental Content

JAMA Psychiatry | 
Editorial | 
Guy M. Goodwin, FMedSci
JAMA Psychiatry. 2015;72(12):1167-1169. doi:10.1001/jamapsychiatry.2015.2014.

JAMA Psychiatry | 
Original Investigation | 
Lars Vedel Kessing, MD, DMSc; Thomas Alexander Gerds, PhD; Bo Feldt-Rasmussen, MD, DMSc; et al.
JAMA Psychiatry. 2015;72(12):1182-1191. doi:10.1001/jamapsychiatry.2015.1834.
Includes: Supplemental Content

JAMA Psychiatry | 
Original Investigation | 
Alexandra Philipsen, MD; Thomas Jans, PhD; Erika Graf, PhD; et al.
JAMA Psychiatry. 2015;72(12):1199-1210. doi:10.1001/jamapsychiatry.2015.2146.
Includes: CME, Supplemental Content

JAMA Internal Medicine | 
Research Letter | 
Christina Mangurian, MD; John W. Newcomer, MD; Eric Vittinghoff, PhD; et al.
JAMA Intern Med. 2015;175(12):1977-1979. doi:10.1001/jamainternmed.2015.6098.

JAMA Psychiatry | 
Viewpoint | 
Daniel R. Weinberger, MD; Ira D. Glick, MD; Donald F. Klein, MD
JAMA Psychiatry. 2015;72(12):1161-1162. doi:10.1001/jamapsychiatry.2015.1743.

JAMA Psychiatry | 
Viewpoint | 
Cindy M. Yee, PhD; Daniel C. Javitt, MD, PhD; Gregory A. Miller, PhD
JAMA Psychiatry. 2015;72(12):1159-1160. doi:10.1001/jamapsychiatry.2015.1900.

JAMA | 
Viewpoint | 
Thomas R. Blair, MD, MS; Randall T. Espinoza, MD, MPH
JAMA. 2015;314(21):2231-2232. doi:10.1001/jama.2015.13328.

JAMA | 
News From the Food and Drug Administration | 
Rebecca Voelker, MSJ
JAMA. 2015;314(17):1789. doi:10.1001/jama.2015.14005.

Sign in

Purchase Options

• Subscribe to the journal
• Rent this article ?

A free personal account provides

• Free current issues on The JAMA Network Reader
• Free quizzes on The JAMA Network Challenge
• Commenting and personalized alerts
From The JAMA Network
JAMA Psychiatry
Research Letter  | 
Trends in Stimulant Medication Use in Commercially Insured Youths and Adults, 2010-2014
Mehmet Burcu, MS; Julie M. Zito, PhD; Leanne Metcalfe, PhD; et al.
JAMA
News From the Food and Drug Administration  | 
Olanzapine Linked With Potentially Fatal Skin Reaction
Rebecca Voelker, MSJ
JAMA
News From the Food and Drug Administration  | 
Antipsychotic Drug May Cause Impulse-Control Problems
Rebecca Voelker, MSJ
JAMA Psychiatry
Editorial  | 
What Are We Learning From Early-Phase Clinical Trials With Glutamate Targeting Medications for the Treatment of Major Depressive Disorder
Gerard Sanacora, MD, PhD